Page 10 - Third Rock News Today

A life sciences company backed by Third Rock Ventures had ambitious plans for going public and achieving rapid growth. At its inception, the company...

With the announcement of a sequel series to That 70s Show in development at Netflix, we take a look at some of the original's most memorable guest stars.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

InteRNA Technologies, a clinical-stage biotech company developing microRNA (miRNA)-based therapeutics with a focus on cancer, announced today the appointment of Andrea van Elsas, PhD, as a new member

A life sciences company backed by Third Rock Ventures* had ambitious plans for going public and achieving rapid growth. Having experienced...

A life sciences company backed by Third Rock Ventures had ambitious plans for going public and achieving rapid growth. At its inception, the company...

Griffin, who recently publicly revealed a substance abuse issue with prescription medication, said that Wednesday would mark her first night without any narcotic pain killers in tow.

--Proceeds to advance company's pipeline of next-generation cytokine immunotherapies----Laura Shawver, Christine Siu join as independent directors-- BASEL, Switzerland and SAN DIEGO, Calif., June 10

Voyager Therapeutics, Inc (NASDAQ: VYGR) CEO and President Andre Turenne will step down as the beleaguered company announced it would move ...

Rett Syndrome Research Trust Establishes Translational Medicine Advisory Board Share Article Four nationally prominent leaders in medical research join the board to advance progress toward a cure for Rett Syndrome “It is an honor to work with such distinguished colleagues on this advisory board; it is also a productive and very meaningful endeavor because of the intense commitment and unusually strong scientific sophistication of the Rett Syndrome Research Trust’s leadership,” said Dr. Hy...